4/24/2013

Patients taking a proton pump inhibitor had higher rates of Campylobacter and Salmonella infections than those not on the drugs, but data show they also were at higher risk for infection before beginning the medication, researchers reported in The American Journal of Gastroenterology. Researchers from Swansea University in the U.K. said infection risks increased over time for all patients. "Thus, increases in [gastrointestinal] infection after a PPI prescription are likely to be owing to a general increase in infection diagnosis rather than a result of the PPI prescription," according to the researchers.

Related Summaries